|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:BAP1-TCEA3 (FusionGDB2 ID:8975) |
Fusion Gene Summary for BAP1-TCEA3 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: BAP1-TCEA3 | Fusion gene ID: 8975 | Hgene | Tgene | Gene symbol | BAP1 | TCEA3 | Gene ID | 9223 | 6920 |
| Gene name | membrane associated guanylate kinase, WW and PDZ domain containing 1 | transcription elongation factor A3 | |
| Synonyms | AIP-3|AIP3|BAIAP1|BAP-1|BAP1|MAGI-1|MAGI-1b|Magi1d|TNRC19|WWP3 | TFIIS|TFIIS.H | |
| Cytomap | 3p14.1 | 1p36.12 | |
| Type of gene | protein-coding | protein-coding | |
| Description | membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1BAI1-associated protein 1WW domain-containing protein 3atrophin-1-interacting protein 3membrane-associated guanylate kinase inverted 1trinucleotide repeat-containing gene 19 | transcription elongation factor A protein 3rhabdomyosarcoma antigen MU-RMS-40.22transcription elongation factor A (SII), 3transcription elongation factor S-II protein 3transcription elongation factor TFIIS.h | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q92560 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000296288, ENST00000460680, | ENST00000461794, ENST00000374601, ENST00000450454, | |
| Fusion gene scores | * DoF score | 12 X 13 X 7=1092 | 7 X 8 X 4=224 |
| # samples | 13 | 8 | |
| ** MAII score | log2(13/1092*10)=-3.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/224*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: BAP1 [Title/Abstract] AND TCEA3 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | BAP1(52439781)-TCEA3(23745632), # samples:2 BAP1(52440269)-TCEA3(23745632), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | BAP1-TCEA3 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. BAP1-TCEA3 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. BAP1-TCEA3 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. BAP1-TCEA3 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. BAP1-TCEA3 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | BAP1 | GO:0022409 | positive regulation of cell-cell adhesion | 20298433 |
| Fusion gene breakpoints across BAP1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across TCEA3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | MESO | TCGA-MQ-A4LC-01A | BAP1 | chr3 | 52439781 | - | TCEA3 | chr1 | 23745632 | - |
| ChimerDB4 | MESO | TCGA-MQ-A4LC-01A | BAP1 | chr3 | 52440269 | - | TCEA3 | chr1 | 23745632 | - |
Top |
Fusion Gene ORF analysis for BAP1-TCEA3 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000296288 | ENST00000461794 | BAP1 | chr3 | 52439781 | - | TCEA3 | chr1 | 23745632 | - |
| 5CDS-5UTR | ENST00000296288 | ENST00000461794 | BAP1 | chr3 | 52440269 | - | TCEA3 | chr1 | 23745632 | - |
| 5CDS-5UTR | ENST00000460680 | ENST00000461794 | BAP1 | chr3 | 52439781 | - | TCEA3 | chr1 | 23745632 | - |
| 5CDS-5UTR | ENST00000460680 | ENST00000461794 | BAP1 | chr3 | 52440269 | - | TCEA3 | chr1 | 23745632 | - |
| Frame-shift | ENST00000296288 | ENST00000374601 | BAP1 | chr3 | 52439781 | - | TCEA3 | chr1 | 23745632 | - |
| Frame-shift | ENST00000296288 | ENST00000450454 | BAP1 | chr3 | 52439781 | - | TCEA3 | chr1 | 23745632 | - |
| Frame-shift | ENST00000460680 | ENST00000374601 | BAP1 | chr3 | 52439781 | - | TCEA3 | chr1 | 23745632 | - |
| Frame-shift | ENST00000460680 | ENST00000450454 | BAP1 | chr3 | 52439781 | - | TCEA3 | chr1 | 23745632 | - |
| In-frame | ENST00000296288 | ENST00000374601 | BAP1 | chr3 | 52440269 | - | TCEA3 | chr1 | 23745632 | - |
| In-frame | ENST00000296288 | ENST00000450454 | BAP1 | chr3 | 52440269 | - | TCEA3 | chr1 | 23745632 | - |
| In-frame | ENST00000460680 | ENST00000374601 | BAP1 | chr3 | 52440269 | - | TCEA3 | chr1 | 23745632 | - |
| In-frame | ENST00000460680 | ENST00000450454 | BAP1 | chr3 | 52440269 | - | TCEA3 | chr1 | 23745632 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000460680 | BAP1 | chr3 | 52440269 | - | ENST00000450454 | TCEA3 | chr1 | 23745632 | - | 2638 | 1255 | 472 | 2232 | 586 |
| ENST00000460680 | BAP1 | chr3 | 52440269 | - | ENST00000374601 | TCEA3 | chr1 | 23745632 | - | 2309 | 1255 | 1230 | 31 | 399 |
| ENST00000296288 | BAP1 | chr3 | 52440269 | - | ENST00000450454 | TCEA3 | chr1 | 23745632 | - | 2148 | 765 | 36 | 1742 | 568 |
| ENST00000296288 | BAP1 | chr3 | 52440269 | - | ENST00000374601 | TCEA3 | chr1 | 23745632 | - | 1819 | 765 | 36 | 1160 | 374 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000460680 | ENST00000450454 | BAP1 | chr3 | 52440269 | - | TCEA3 | chr1 | 23745632 | - | 0.008255282 | 0.9917447 |
| ENST00000460680 | ENST00000374601 | BAP1 | chr3 | 52440269 | - | TCEA3 | chr1 | 23745632 | - | 0.006744993 | 0.993255 |
| ENST00000296288 | ENST00000450454 | BAP1 | chr3 | 52440269 | - | TCEA3 | chr1 | 23745632 | - | 0.008400148 | 0.9915999 |
| ENST00000296288 | ENST00000374601 | BAP1 | chr3 | 52440269 | - | TCEA3 | chr1 | 23745632 | - | 0.004570492 | 0.9954295 |
Top |
Fusion Genomic Features for BAP1-TCEA3 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for BAP1-TCEA3 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:52439781/chr1:23745632) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| BAP1 | . |
| FUNCTION: Deubiquitinating enzyme that plays a key role in chromatin by mediating deubiquitination of histone H2A and HCFC1 (PubMed:12485996, PubMed:18757409, PubMed:20436459, PubMed:25451922). Catalytic component of the PR-DUB complex, a complex that specifically mediates deubiquitination of histone H2A monoubiquitinated at 'Lys-119' (H2AK119ub1) (PubMed:20436459, PubMed:25451922). Does not deubiquitinate monoubiquitinated histone H2B (PubMed:20436459). Acts as a regulator of cell growth by mediating deubiquitination of HCFC1 N-terminal and C-terminal chains, with some specificity toward 'Lys-48'-linked polyubiquitin chains compared to 'Lys-63'-linked polyubiquitin chains (PubMed:19188440, PubMed:19815555). Deubiquitination of HCFC1 does not lead to increase stability of HCFC1 (PubMed:19188440, PubMed:19815555). Interferes with the BRCA1 and BARD1 heterodimer activity by inhibiting their ability to mediate ubiquitination and autoubiquitination (PubMed:19117993). It however does not mediate deubiquitination of BRCA1 and BARD1 (PubMed:19117993). Able to mediate autodeubiquitination via intramolecular interactions to couteract monoubiquitination at the nuclear localization signal (NLS), thereby protecting it from cytoplasmic sequestration (PubMed:24703950). Acts as a tumor suppressor (PubMed:9528852). {ECO:0000269|PubMed:12485996, ECO:0000269|PubMed:18757409, ECO:0000269|PubMed:19117993, ECO:0000269|PubMed:19188440, ECO:0000269|PubMed:19815555, ECO:0000269|PubMed:20436459, ECO:0000269|PubMed:24703950, ECO:0000269|PubMed:25451922, ECO:0000269|PubMed:9528852}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | TCEA3 | chr3:52440269 | chr1:23745632 | ENST00000450454 | 0 | 11 | 130_173 | 23 | 349.0 | Compositional bias | Note=Ser-rich | |
| Tgene | TCEA3 | chr3:52440269 | chr1:23745632 | ENST00000450454 | 0 | 11 | 187_303 | 23 | 349.0 | Domain | TFIIS central | |
| Tgene | TCEA3 | chr3:52440269 | chr1:23745632 | ENST00000450454 | 0 | 11 | 306_346 | 23 | 349.0 | Zinc finger | TFIIS-type |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | BAP1 | chr3:52440269 | chr1:23745632 | ENST00000460680 | - | 9 | 17 | 630_661 | 261 | 730.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Tgene | TCEA3 | chr3:52440269 | chr1:23745632 | ENST00000450454 | 0 | 11 | 5_82 | 23 | 349.0 | Domain | TFIIS N-terminal |
Top |
Fusion Gene Sequence for BAP1-TCEA3 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >8975_8975_1_BAP1-TCEA3_BAP1_chr3_52440269_ENST00000296288_TCEA3_chr1_23745632_ENST00000374601_length(transcript)=1819nt_BP=765nt CCTGGACATGGCGCTGAGGGGCCGCCCCGCGGGAAGATGAATAAGGGCTGGCTGGAGCTGGAGAGCGACCCAGGCCTCTTCACCCTGCTC GTGGAAGATTTCGGTGTCAAGGGGGTGCAAGTGGAGGAGATCTACGACCTTCAGAGCAAATGTCAGGGCCCTGTATATGGATTTATCTTC CTGTTCAAATGGATCGAAGAGCGCCGGTCCCGGCGAAAGGTCTCTACCTTGGTGGATGATACGTCCGTGATTGATGATGATATTGTGAAT AACATGTTCTTTGCCCACCAGCTGATACCCAACTCTTGTGCAACTCATGCCTTGCTGAGCGTGCTCCTGAACTGCAGCAGCGTGGACCTG GGACCCACCCTGAGTCGCATGAAGGACTTCACCAAGGGTTTCAGCCCTGAGAGCAAAGGATATGCGATTGGCAATGCCCCGGAGTTGGCC AAGGCCCATAATAGCCATGCCAGGCCCGAGCCACGCCACCTCCCTGAGAAGCAGAATGGCCTTAGTGCAGTGCGGACCATGGAGGCGTTC CACTTTGTCAGCTATGTGCCTATCACAGGCCGGCTCTTTGAGCTGGATGGGCTGAAGGTCTACCCCATTGACCATGGGCCCTGGGGGGAG GACGAGGAGTGGACAGACAAGGCCCGGCGGGTCATCATGGAGCGTATCGGCCTCGCCACTGCAGGGATCAAGTATGAGGCCAGGCTGCAT GTGCTGAAGGTGAACCGTCAGACAGTACTAGAGGCTCTGCAGCAGGAAGGGGCCCTGGACCTTCTGAAGAAGCTGCACAGCTGCCAGATG TCCATCCAGCTACTACAGACAACCAGGATTGGAGTTGCTGTTAATGGGGTCCGCAAGCACTGCTCAGACAAGGAGGTGGTGTCCTTGGCC AAAGTCCTTATCAAAAACTGGAAGCGGCTGCTAGACTCCCCTGGACCCCCAAAAGGAGAAAAAGGAGAGGAAAGAGAAAAGGCAAAGAAG AAGGAAAAAGGGCTTGAGTGTTCAGACTGGAAGCCAGAAGCAGGCCTTTCTCCACCAAGGAAAAAACGAGAAGACCCCAAAACCAGGAGA GACTCTGTGGACTCCAAGTCTTCTGCCTCCTCCTCTCCAAAAAGACCATCGGTGGAAAGAGCATGCTCGCTGATGCAGTAACTGAAATGC CCTCGAGGTGGCGCACAGAAGCAGCGGGCCCGGCCTCCAGATGCCTCTACTCAGACCTGGGGCAGGAGGATTTTCTAAGGACTGGTGCGG TGCGGGCACATCCGGGGAGCAGAAGGAAGCTGTTGATAAATCCAACCTCCCACCCCGGCCGATGATGCCCTCTCTGCAGTTTGGCTCAGT TCCCAGGCGTGTGCATTGAAAGCAAAATGAGTGTGGCTGCCTGAAATGCTGCCCAGACACGAATTCCAGCCAGCCAGCCAGCTCCTAACC GGGGAGGCGGGACCAGGGCTGGGTGTGCCCTGCCAGGAAGGTGGGAAGAAATGCTCCAAACAGCCTAGTCTTGCTCAGGTAGGAGGACTC TGGAAACCTCTCTTTTAAAGACACAGTTGATGTGTTGAAAAGAATTTGGAAGGGCGACAGGCAGGTTCGTGGTCTGACTATACCCTTTGC TAGTTGGATGGATAACTTGGGGCAGTAACTTGGATGGATAATTCAGTTCAGCTCTCTGAGCTTCAGTCTACTGATCTGTAAAATGGAGAC AATTATGAACCCCTTTCAAGGTCATTGTGAGGATTAAATGAGGTAATGAAATACCCAGCACTGTTCCCAAACCATGTAAATGCTCAATAA >8975_8975_1_BAP1-TCEA3_BAP1_chr3_52440269_ENST00000296288_TCEA3_chr1_23745632_ENST00000374601_length(amino acids)=374AA_BP=240 MNKGWLELESDPGLFTLLVEDFGVKGVQVEEIYDLQSKCQGPVYGFIFLFKWIEERRSRRKVSTLVDDTSVIDDDIVNNMFFAHQLIPNS CATHALLSVLLNCSSVDLGPTLSRMKDFTKGFSPESKGYAIGNAPELAKAHNSHARPEPRHLPEKQNGLSAVRTMEAFHFVSYVPITGRL FELDGLKVYPIDHGPWGEDEEWTDKARRVIMERIGLATAGIKYEARLHVLKVNRQTVLEALQQEGALDLLKKLHSCQMSIQLLQTTRIGV AVNGVRKHCSDKEVVSLAKVLIKNWKRLLDSPGPPKGEKGEEREKAKKKEKGLECSDWKPEAGLSPPRKKREDPKTRRDSVDSKSSASSS -------------------------------------------------------------- >8975_8975_2_BAP1-TCEA3_BAP1_chr3_52440269_ENST00000296288_TCEA3_chr1_23745632_ENST00000450454_length(transcript)=2148nt_BP=765nt CCTGGACATGGCGCTGAGGGGCCGCCCCGCGGGAAGATGAATAAGGGCTGGCTGGAGCTGGAGAGCGACCCAGGCCTCTTCACCCTGCTC GTGGAAGATTTCGGTGTCAAGGGGGTGCAAGTGGAGGAGATCTACGACCTTCAGAGCAAATGTCAGGGCCCTGTATATGGATTTATCTTC CTGTTCAAATGGATCGAAGAGCGCCGGTCCCGGCGAAAGGTCTCTACCTTGGTGGATGATACGTCCGTGATTGATGATGATATTGTGAAT AACATGTTCTTTGCCCACCAGCTGATACCCAACTCTTGTGCAACTCATGCCTTGCTGAGCGTGCTCCTGAACTGCAGCAGCGTGGACCTG GGACCCACCCTGAGTCGCATGAAGGACTTCACCAAGGGTTTCAGCCCTGAGAGCAAAGGATATGCGATTGGCAATGCCCCGGAGTTGGCC AAGGCCCATAATAGCCATGCCAGGCCCGAGCCACGCCACCTCCCTGAGAAGCAGAATGGCCTTAGTGCAGTGCGGACCATGGAGGCGTTC CACTTTGTCAGCTATGTGCCTATCACAGGCCGGCTCTTTGAGCTGGATGGGCTGAAGGTCTACCCCATTGACCATGGGCCCTGGGGGGAG GACGAGGAGTGGACAGACAAGGCCCGGCGGGTCATCATGGAGCGTATCGGCCTCGCCACTGCAGGGATCAAGTATGAGGCCAGGCTGCAT GTGCTGAAGGTGAACCGTCAGACAGTACTAGAGGCTCTGCAGCAGGAAGGGGCCCTGGACCTTCTGAAGAAGCTGCACAGCTGCCAGATG TCCATCCAGCTACTACAGACAACCAGGATTGGAGTTGCTGTTAATGGGGTCCGCAAGCACTGCTCAGACAAGGAGGTGGTGTCCTTGGCC AAAGTCCTTATCAAAAACTGGAAGCGGCTGCTAGACTCCCCTGGACCCCCAAAAGGAGAAAAAGGAGAGGAAAGAGAAAAGGCAAAGAAG AAGGAAAAAGGGCTTGAGTGTTCAGACTGGAAGCCAGAAGCAGGCCTTTCTCCACCAAGGAAAAAACGAGAAGACCCCAAAACCAGGAGA GACTCTGTGGACTCCAAGTCTTCTGCCTCCTCCTCTCCAAAAAGACCATCGGTGGAAAGATCAAACAGCAGCAAATCAAAAGCGGAGAGC CCCAAAACACCTAGCAGCCCCTTGACCCCCACGTTTGCCTCTTCCATGTGTCTCCTGGCCCCCTGCTATCTCACAGGGGACTCTGTCCGG GACAAGTGTGTGGAGATGCTGTCAGCAGCCCTGAAGGCGGACGATGATTACAAGGACTATGGAGTCAACTGTGACAAGATGGCATCAGAA ATCGAAGATCATATCTACCAAGAGCTCAAGAGCACGGACATGAAGTACCGGAACCGCGTGCGCAGCCGCATAAGCAACCTCAAGGACCCC AGGAACCCCGGCCTGCGGCGGAACGTGCTCAGTGGGGCCATCTCCGCAGGGCTTATAGCCAAGATGACGGCAGAGGAAATGGCCAGTGAT GAACTGAGGGAGTTGAGGAATGCCATGACCCAGGAGGCCATCCGTGAGCACCAGATGGCCAAGACTGGCGGCACCACCACTGACCTCTTC CAGTGCAGCAAATGCAAGAAGAAGAACTGCACCTATAACCAGGTGCAGACACGCAGTGCTGATGAGCCCATGACTACCTTTGTCTTATGC AATGAATGTGGCAATCGCTGGAAGTTCTGCTGATGGAACAGCCAGCCATGAACAAGGTGAGGAAGAAGAAAGAGGAAGCGCTGAATTATC TGAACTGGAGAAGCAATAAAAATTAAAGTGAAGGAAAATACTGAACTCTGTCTGAGTGGGATGGTATGAGTTAGAGGAAGAATTCTCTTG CAAATTAATAATCGGTCATTAGAAACAATTGGTTAATGGGGGAGCCTAATTGGAGAATGATGCTGAGAATTTGTATTGATGAACCTCTTT TAGAAACTGCAGAGGGCTGGGCACGGTGGTTTATGGCTGTAATCTGCAAACTCTGGGAGGCTGAGGTGGGAGAATCGCTTAACCCCAGAA >8975_8975_2_BAP1-TCEA3_BAP1_chr3_52440269_ENST00000296288_TCEA3_chr1_23745632_ENST00000450454_length(amino acids)=568AA_BP=240 MNKGWLELESDPGLFTLLVEDFGVKGVQVEEIYDLQSKCQGPVYGFIFLFKWIEERRSRRKVSTLVDDTSVIDDDIVNNMFFAHQLIPNS CATHALLSVLLNCSSVDLGPTLSRMKDFTKGFSPESKGYAIGNAPELAKAHNSHARPEPRHLPEKQNGLSAVRTMEAFHFVSYVPITGRL FELDGLKVYPIDHGPWGEDEEWTDKARRVIMERIGLATAGIKYEARLHVLKVNRQTVLEALQQEGALDLLKKLHSCQMSIQLLQTTRIGV AVNGVRKHCSDKEVVSLAKVLIKNWKRLLDSPGPPKGEKGEEREKAKKKEKGLECSDWKPEAGLSPPRKKREDPKTRRDSVDSKSSASSS PKRPSVERSNSSKSKAESPKTPSSPLTPTFASSMCLLAPCYLTGDSVRDKCVEMLSAALKADDDYKDYGVNCDKMASEIEDHIYQELKST DMKYRNRVRSRISNLKDPRNPGLRRNVLSGAISAGLIAKMTAEEMASDELRELRNAMTQEAIREHQMAKTGGTTTDLFQCSKCKKKNCTY -------------------------------------------------------------- >8975_8975_3_BAP1-TCEA3_BAP1_chr3_52440269_ENST00000460680_TCEA3_chr1_23745632_ENST00000374601_length(transcript)=2309nt_BP=1255nt CGCTCCGCCCCTCCCCTCGCAGCACCCGGGCCTAGTACTGCCCGTCCCGCCCCTCCTCTCGAGCCTCAGCGCTCAGCATCGCCCGGACCC CCTCTTCCCTTCGCCCGCCTCGTCCCGACCCTCCCCTTCGCCCCCGTCCCGCCCCGCCCCTCCCCTTCGCCCCCGTCCCGTCCCGCCCCG CCCCTCCCCTTCGCCCCCGTCCCTCCCCTTCGCCCCCGTCCCTCCGCGCGTGCGCGTTCGCCTTCGAGCGCATGCCCGCATCTGCTGTCC GACAGGCGGAAGACGAGCCCAGAGGCGGAGCAGGGCCGTCGCGCCTTGGTGACGTCTGCCGCCGGCGCGGGCGGGTGACGCGACTGGGCC CGTTGTCTGTGTGTGGGACTGAGGGGCCCCGGGGGCGGTGGGGGCTCCCGGTGGGGGCAGCGGTGGGGAGGGAGGGCCTGGACATGGCGC TGAGGGGCCGCCCCGCGGGAAGATGAATAAGGGCTGGCTGGAGCTGGAGAGCGACCCAGGCCTCTTCACCCTGCTCGTGGAAGATTTCGG TGTCAAGGGGGTGCAAGTGGAGGAGATCTACGACCTTCAGAGCAAATGTCAGGGCCCTGTATATGGATTTATCTTCCTGTTCAAATGGAT CGAAGAGCGCCGGTCCCGGCGAAAGGTCTCTACCTTGGTGGATGATACGTCCGTGATTGATGATGATATTGTGAATAACATGTTCTTTGC CCACCAGCTGATACCCAACTCTTGTGCAACTCATGCCTTGCTGAGCGTGCTCCTGAACTGCAGCAGCGTGGACCTGGGACCCACCCTGAG TCGCATGAAGGACTTCACCAAGGGTTTCAGCCCTGAGAGCAAAGGATATGCGATTGGCAATGCCCCGGAGTTGGCCAAGGCCCATAATAG CCATGCCAGGCCCGAGCCACGCCACCTCCCTGAGAAGCAGAATGGCCTTAGTGCAGTGCGGACCATGGAGGCGTTCCACTTTGTCAGCTA TGTGCCTATCACAGGCCGGCTCTTTGAGCTGGATGGGCTGAAGGTCTACCCCATTGACCATGGGCCCTGGGGGGAGGACGAGGAGTGGAC AGACAAGGCCCGGCGGGTCATCATGGAGCGTATCGGCCTCGCCACTGCAGGGGAGCCCTACCACGACATCCGCTTCAACCTGATGGCAGT GGTGCCCGACCGCAGGATCAAGTATGAGGCCAGGCTGCATGTGCTGAAGGTGAACCGTCAGACAGTACTAGAGGCTCTGCAGCAGGAAGG GGCCCTGGACCTTCTGAAGAAGCTGCACAGCTGCCAGATGTCCATCCAGCTACTACAGACAACCAGGATTGGAGTTGCTGTTAATGGGGT CCGCAAGCACTGCTCAGACAAGGAGGTGGTGTCCTTGGCCAAAGTCCTTATCAAAAACTGGAAGCGGCTGCTAGACTCCCCTGGACCCCC AAAAGGAGAAAAAGGAGAGGAAAGAGAAAAGGCAAAGAAGAAGGAAAAAGGGCTTGAGTGTTCAGACTGGAAGCCAGAAGCAGGCCTTTC TCCACCAAGGAAAAAACGAGAAGACCCCAAAACCAGGAGAGACTCTGTGGACTCCAAGTCTTCTGCCTCCTCCTCTCCAAAAAGACCATC GGTGGAAAGAGCATGCTCGCTGATGCAGTAACTGAAATGCCCTCGAGGTGGCGCACAGAAGCAGCGGGCCCGGCCTCCAGATGCCTCTAC TCAGACCTGGGGCAGGAGGATTTTCTAAGGACTGGTGCGGTGCGGGCACATCCGGGGAGCAGAAGGAAGCTGTTGATAAATCCAACCTCC CACCCCGGCCGATGATGCCCTCTCTGCAGTTTGGCTCAGTTCCCAGGCGTGTGCATTGAAAGCAAAATGAGTGTGGCTGCCTGAAATGCT GCCCAGACACGAATTCCAGCCAGCCAGCCAGCTCCTAACCGGGGAGGCGGGACCAGGGCTGGGTGTGCCCTGCCAGGAAGGTGGGAAGAA ATGCTCCAAACAGCCTAGTCTTGCTCAGGTAGGAGGACTCTGGAAACCTCTCTTTTAAAGACACAGTTGATGTGTTGAAAAGAATTTGGA AGGGCGACAGGCAGGTTCGTGGTCTGACTATACCCTTTGCTAGTTGGATGGATAACTTGGGGCAGTAACTTGGATGGATAATTCAGTTCA GCTCTCTGAGCTTCAGTCTACTGATCTGTAAAATGGAGACAATTATGAACCCCTTTCAAGGTCATTGTGAGGATTAAATGAGGTAATGAA >8975_8975_3_BAP1-TCEA3_BAP1_chr3_52440269_ENST00000460680_TCEA3_chr1_23745632_ENST00000374601_length(amino acids)=399AA_BP= MTVHLQHMQPGLILDPAVGHHCHQVEADVVVGLPCSGEADTLHDDPPGLVCPLLVLPPGPMVNGVDLQPIQLKEPACDRHIADKVERLHG PHCTKAILLLREVAWLGPGMAIMGLGQLRGIANRISFALRAETLGEVLHATQGGSQVHAAAVQEHAQQGMSCTRVGYQLVGKEHVIHNII INHGRIIHQGRDLSPGPALFDPFEQEDKSIYRALTFALKVVDLLHLHPLDTEIFHEQGEEAWVALQLQPALIHLPAGRPLSAMSRPSLPT AAPTGSPHRPRGPSVPHTDNGPSRVTRPRRRQTSPRRDGPAPPLGSSSACRTADAGMRSKANAHARRDGGEGEGRGRRGGAGRDGTGAKG -------------------------------------------------------------- >8975_8975_4_BAP1-TCEA3_BAP1_chr3_52440269_ENST00000460680_TCEA3_chr1_23745632_ENST00000450454_length(transcript)=2638nt_BP=1255nt CGCTCCGCCCCTCCCCTCGCAGCACCCGGGCCTAGTACTGCCCGTCCCGCCCCTCCTCTCGAGCCTCAGCGCTCAGCATCGCCCGGACCC CCTCTTCCCTTCGCCCGCCTCGTCCCGACCCTCCCCTTCGCCCCCGTCCCGCCCCGCCCCTCCCCTTCGCCCCCGTCCCGTCCCGCCCCG CCCCTCCCCTTCGCCCCCGTCCCTCCCCTTCGCCCCCGTCCCTCCGCGCGTGCGCGTTCGCCTTCGAGCGCATGCCCGCATCTGCTGTCC GACAGGCGGAAGACGAGCCCAGAGGCGGAGCAGGGCCGTCGCGCCTTGGTGACGTCTGCCGCCGGCGCGGGCGGGTGACGCGACTGGGCC CGTTGTCTGTGTGTGGGACTGAGGGGCCCCGGGGGCGGTGGGGGCTCCCGGTGGGGGCAGCGGTGGGGAGGGAGGGCCTGGACATGGCGC TGAGGGGCCGCCCCGCGGGAAGATGAATAAGGGCTGGCTGGAGCTGGAGAGCGACCCAGGCCTCTTCACCCTGCTCGTGGAAGATTTCGG TGTCAAGGGGGTGCAAGTGGAGGAGATCTACGACCTTCAGAGCAAATGTCAGGGCCCTGTATATGGATTTATCTTCCTGTTCAAATGGAT CGAAGAGCGCCGGTCCCGGCGAAAGGTCTCTACCTTGGTGGATGATACGTCCGTGATTGATGATGATATTGTGAATAACATGTTCTTTGC CCACCAGCTGATACCCAACTCTTGTGCAACTCATGCCTTGCTGAGCGTGCTCCTGAACTGCAGCAGCGTGGACCTGGGACCCACCCTGAG TCGCATGAAGGACTTCACCAAGGGTTTCAGCCCTGAGAGCAAAGGATATGCGATTGGCAATGCCCCGGAGTTGGCCAAGGCCCATAATAG CCATGCCAGGCCCGAGCCACGCCACCTCCCTGAGAAGCAGAATGGCCTTAGTGCAGTGCGGACCATGGAGGCGTTCCACTTTGTCAGCTA TGTGCCTATCACAGGCCGGCTCTTTGAGCTGGATGGGCTGAAGGTCTACCCCATTGACCATGGGCCCTGGGGGGAGGACGAGGAGTGGAC AGACAAGGCCCGGCGGGTCATCATGGAGCGTATCGGCCTCGCCACTGCAGGGGAGCCCTACCACGACATCCGCTTCAACCTGATGGCAGT GGTGCCCGACCGCAGGATCAAGTATGAGGCCAGGCTGCATGTGCTGAAGGTGAACCGTCAGACAGTACTAGAGGCTCTGCAGCAGGAAGG GGCCCTGGACCTTCTGAAGAAGCTGCACAGCTGCCAGATGTCCATCCAGCTACTACAGACAACCAGGATTGGAGTTGCTGTTAATGGGGT CCGCAAGCACTGCTCAGACAAGGAGGTGGTGTCCTTGGCCAAAGTCCTTATCAAAAACTGGAAGCGGCTGCTAGACTCCCCTGGACCCCC AAAAGGAGAAAAAGGAGAGGAAAGAGAAAAGGCAAAGAAGAAGGAAAAAGGGCTTGAGTGTTCAGACTGGAAGCCAGAAGCAGGCCTTTC TCCACCAAGGAAAAAACGAGAAGACCCCAAAACCAGGAGAGACTCTGTGGACTCCAAGTCTTCTGCCTCCTCCTCTCCAAAAAGACCATC GGTGGAAAGATCAAACAGCAGCAAATCAAAAGCGGAGAGCCCCAAAACACCTAGCAGCCCCTTGACCCCCACGTTTGCCTCTTCCATGTG TCTCCTGGCCCCCTGCTATCTCACAGGGGACTCTGTCCGGGACAAGTGTGTGGAGATGCTGTCAGCAGCCCTGAAGGCGGACGATGATTA CAAGGACTATGGAGTCAACTGTGACAAGATGGCATCAGAAATCGAAGATCATATCTACCAAGAGCTCAAGAGCACGGACATGAAGTACCG GAACCGCGTGCGCAGCCGCATAAGCAACCTCAAGGACCCCAGGAACCCCGGCCTGCGGCGGAACGTGCTCAGTGGGGCCATCTCCGCAGG GCTTATAGCCAAGATGACGGCAGAGGAAATGGCCAGTGATGAACTGAGGGAGTTGAGGAATGCCATGACCCAGGAGGCCATCCGTGAGCA CCAGATGGCCAAGACTGGCGGCACCACCACTGACCTCTTCCAGTGCAGCAAATGCAAGAAGAAGAACTGCACCTATAACCAGGTGCAGAC ACGCAGTGCTGATGAGCCCATGACTACCTTTGTCTTATGCAATGAATGTGGCAATCGCTGGAAGTTCTGCTGATGGAACAGCCAGCCATG AACAAGGTGAGGAAGAAGAAAGAGGAAGCGCTGAATTATCTGAACTGGAGAAGCAATAAAAATTAAAGTGAAGGAAAATACTGAACTCTG TCTGAGTGGGATGGTATGAGTTAGAGGAAGAATTCTCTTGCAAATTAATAATCGGTCATTAGAAACAATTGGTTAATGGGGGAGCCTAAT TGGAGAATGATGCTGAGAATTTGTATTGATGAACCTCTTTTAGAAACTGCAGAGGGCTGGGCACGGTGGTTTATGGCTGTAATCTGCAAA CTCTGGGAGGCTGAGGTGGGAGAATCGCTTAACCCCAGAAGTTTGAGTCCAGCCCAGGCAACACAGCAAGACCCCATCTCTATAAAAAGA >8975_8975_4_BAP1-TCEA3_BAP1_chr3_52440269_ENST00000460680_TCEA3_chr1_23745632_ENST00000450454_length(amino acids)=586AA_BP=258 MNKGWLELESDPGLFTLLVEDFGVKGVQVEEIYDLQSKCQGPVYGFIFLFKWIEERRSRRKVSTLVDDTSVIDDDIVNNMFFAHQLIPNS CATHALLSVLLNCSSVDLGPTLSRMKDFTKGFSPESKGYAIGNAPELAKAHNSHARPEPRHLPEKQNGLSAVRTMEAFHFVSYVPITGRL FELDGLKVYPIDHGPWGEDEEWTDKARRVIMERIGLATAGEPYHDIRFNLMAVVPDRRIKYEARLHVLKVNRQTVLEALQQEGALDLLKK LHSCQMSIQLLQTTRIGVAVNGVRKHCSDKEVVSLAKVLIKNWKRLLDSPGPPKGEKGEEREKAKKKEKGLECSDWKPEAGLSPPRKKRE DPKTRRDSVDSKSSASSSPKRPSVERSNSSKSKAESPKTPSSPLTPTFASSMCLLAPCYLTGDSVRDKCVEMLSAALKADDDYKDYGVNC DKMASEIEDHIYQELKSTDMKYRNRVRSRISNLKDPRNPGLRRNVLSGAISAGLIAKMTAEEMASDELRELRNAMTQEAIREHQMAKTGG -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for BAP1-TCEA3 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | BAP1 | chr3:52440269 | chr1:23745632 | ENST00000460680 | - | 9 | 17 | 596_721 | 261.0 | 730.0 | BRCA1 |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for BAP1-TCEA3 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for BAP1-TCEA3 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies